Sectoral Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44,383	Closed	-$296K	–	106
2025 Q1	$296K	Buy	44,383 +4,200	+10%	+$41.5K	0.23%	62
2024 Q4	$505K	Sell	40,183 -3,200	-7%	-$48.2K	0.34%	58
2024 Q3	$801K	Buy	43,383 +30,853	+246%	+$632K	0.47%	54
2024 Q2	$270K	Sell	12,530 -2,280	-15%	-$52.4K	0.11%	82
2024 Q1	$399K	Buy	14,810 +2,530	+21%	+$71.9K	0.16%	79
2023 Q4	$368K	Sell	12,280 -214,750	-95%	-$4.74M	0.16%	88
2023 Q3	$4.65M	Buy	227,030 +36,240	+19%	+$659K	0.91%	47
2023 Q2	$3.79M	Hold	190,790	–	–	0.63%	67
2023 Q1	$3.27M	Hold	190,790	–	–	0.63%	67
2022 Q4	$3.73M	Sell	190,790 -80,000	-30%	-$1.47M	0.72%	59
2022 Q3	$4.32M	Hold	270,790	–	–	0.85%	53
2022 Q2	$3.73M	Sell	270,790 -33,185	-11%	-$396K	0.75%	57
2022 Q1	$4.82M	Sell	303,975 -79,000	-21%	-$1.36M	0.86%	48
2021 Q4	$8.36M	Sell	382,975 -123,110	-24%	-$3.36M	1.26%	33
2021 Q3	$15.1M	Buy	506,085 +35,950	+8%	+$1.31M	1.26%	23
2021 Q2	$20.8M	Buy	470,135 +22,250	+5%	+$966K	1.68%	14
2021 Q1	$19.9M	Buy	447,885 +80,500	+22%	+$4.42M	1.51%	23
2020 Q4	$20.1M	Buy	+367,385	New	+$13.4M	1.42%	29
2018 Q3	–	Sell	-237,158	Closed	-$4.66M	–	172
2018 Q2	$4.66M	Buy	237,158 +21,000	+10%	+$397K	0.52%	51
2018 Q1	$4.05M	Buy	+216,158	New	+$3.52M	0.44%	58

Other funds holding RCKT